CCG-100602
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 µM) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
478.82
Molecular Formula
C21H17ClF6N2O2
Notes
Research use only, not for human use.
Receptor
Rho
CAS Number
1207113-88-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
